Characterizing Late-season Influenza Vaccine Responses to Compare the 2023 and 2024 Vaccine Formulations
NCT06567860
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
23
Enrollment
OTHER
Sponsor class
Conditions
Influenza A
Interventions
BIOLOGICAL:
Influenza Fluzone vaccine
Sponsor
La Jolla Institute for Immunology